Nvidia Stock Jumps as Goldman Sachs Adds Chipmaker to "Conviction Buy" List

Nvidia stock jumped on Tuesday after Goldman Sachs added the chipmaker to its “Conviction Buy” list. Goldman analysts upgraded Nvidia stock to “Buy” from “Neutral” and raised their price target to $325 from $280.

In a note to investors, Goldman analysts said that Nvidia is well-positioned to benefit from the long-term secular trends of data center growth and artificial intelligence (AI) adoption.

Goldman analysts said the data center market is expected to grow at a compound annual growth rate (CAGR) of 18% over the next five years, driven by the growing demand for AI and machine learning workloads. Nvidia is a leading provider of data center graphics processing units (GPUs) used for AI and machine learning applications.

Goldman analysts also said that Nvidia is well-positioned to benefit from the growing adoption of AI in various industries, including healthcare, manufacturing, and retail.

The upgrade from Goldman Sachs comes as Nvidia stock has been under pressure in recent months due to concerns about a potential slowdown in the semiconductor market. However, Goldman analysts believe that Nvidia is a “uniquely positioned” company well-positioned to weather any short-term market volatility.

Nvidia stock is up more than 10% in pre-market trading on Tuesday following the Goldman Sachs upgrade.

The upgrade from Goldman Sachs is a positive sign for Nvidia stock. Goldman analysts are bullish on the company’s long-term prospects and believe that Nvidia is well-positioned to benefit from the secular trends of data center growth and AI adoption.

Investors should watch Nvidia stock in the coming weeks and months to see if it can maintain its momentum.

Editor's Choice

Posts You Might Like

how to use DrPen

Dr. Pen is a micro-needling device used for skin rejuvenation, typically for facial treatments to improve the appearance of wrinkles, scars, and overall skin texture.

Building a “Brick-and-click” Future | Suresh Madan

Changes in how health care is delivered have had to occur due to the COVID-19 pandemic, and Healthcare systems are adjusting the way they triage, evaluate, and care for patients via methods that do not rely on in-person encounters.

The-corporate-magazine-15

Leave us a message

Subscribe

Fill the form our team will contact you

Advertise with us

Fill the form our team will contact you​